Derivation Web

source_358b2d9357934805

by researka:v2 · 2026-07-10 19:08:22.253641+04:00

# Source literature boundary memo

## Research question

Across retrieved source-level receipts for telomere, which endpoints show directionally favorable versus null/non-convergent signals, and what matched PICO remains untested?

## Selection criteria

The source-literature selector kept telomere because the candidate bundle met the public source rule: 5 citable papers, 5 distinct fact-backed source identities, topic-overlapping source facts, and enough shared scope to compare metric/context disagreement. It excludes duplicate reports, metadata-only title matches, off-topic papers, and sources without fact-level extraction before treating the bundle as a coherent scoping front rather than proof of intervention efficacy.

## Plain-language synthesis

Bounded signal: telomere is only a source-level context map; the selected receipts do not establish one pooled effect.

## Boundary map

- Short telomere length is associated with impaired cognitive performance in European ancestry cohorts [primary; 2017] doi:10.1038/tp.2017.73
  - Finding: longer telomeres were associated with better scores on DSST (β=0.051 per s.d.-increase of TL; 95% CI: 0.024, 0.077; P=0.0002)
  - Population: European ancestry cohorts (N=17,052; mean age=59.2±8.8 years)
  - Intervention/exposure: longer telomere length (per s.d.-increase of TL)
  - Comparator: shorter telomere length
- Genetically Predicted Telomere Length and Its Relationship With Alzheimer’s Disease [primary; 2021] doi:10.3389/fgene.2021.595864
  - Finding: longer telomeres were associated with lower risks of AD (odds ratio = 0.79, 95% confidence interval: 0.67, 0.93, P = 0.004)
  - Population: Alzheimer's disease GWAS summary statistics
  - Intervention/exposure: longer genetically predicted leukocyte telomere length (20 SNPs as instrumental variables)
  - Comparator: shorter genetically predicted leukocyte telomere length
  - Endpoint/metric: odds ratio for Alzheimer's disease risk
- Causal association of epigenetic aging and COVID-19 severity and susceptibility: A bidirectional Mendelian randomization study [primary; 2022] doi:10.3389/fmed.2022.989950
  - Finding: aging was not a risk factor for the increased severity of COVID-19 (P > 0.05).
  - Population: COVID-19 Host Genetics Initiative cohort
  - Intervention/exposure: epigenetic age and telomere length
- Telomere Length and All-Cause Mortality: A Meta-analysis [review; 2018] doi:10.1016/j.arr.2018.09.002
  - Finding: one standard deviation (SD) decrement of leukocyte TL corresponded to 13% increased all-cause mortality risk (95% confidence interval [CI]: 7%-19%)
  - Population: Swedish Twin Registry cohort, 12,083 individuals with 2517 deaths
  - Intervention/exposure: one standard deviation decrement in leukocyte telomere length
- Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis [primary; 2018] doi:10.1164/rccm.201809-1646oc
  - Finding: In PANTHER-IPF, exposure to prednisone/azathioprine/N-acetylcysteine was associated with a higher composite endpoint for those with an LTL less than the 10th percentile (hazard ratio, 2.84; 95% confidence interval, 1.02–7.87; P = 0.045).
  - Population: patients with idiopathic pulmonary fibrosis and leukocyte telomere length less than the 10th percentile
  - Intervention/exposure: prednisone/azathioprine/N-acetylcysteine
  - Comparator: placebo

## Source synthesis

Bounded signal: telomere is only a source-level context map; the selected receipts do not establish one pooled effect.


## Evidence matrix

### Effect-bearing comparison

| Outcome family | Receipt | Evidence role | Population/setting | Metric | Extracted finding |
|---|---|---|---|---|---|
| outcome-specific | Short telomere length is associated with impaired cognitive performance... | directionally favorable | European ancestry cohorts (N=17,052; mean... | - | longer telomeres were associated with better scores on DSST (β=0.051 per s.d.-increase of TL; 95% CI: 0.024... |
| odds ratio for | Genetically Predicted Telomere Length and Its Relationship With... | directionally favorable | Alzheimer's disease GWAS summary statistics | odds ratio for Alzheimer's disease risk | longer telomeres were associated with lower risks of AD (odds ratio = 0.79, 95% confidence interval: 0.67... |
| outcome-specific | Telomere Length and All-Cause Mortality: A Meta-analysis | directionally favorable | Swedish Twin Registry cohort, 12,083... | - | one standard deviation (SD) decrement of leukocyte TL corresponded to 13% increased all-cause mortality risk... |

### Context-only receipts

| Outcome family | Receipt | Evidence role | Population/setting | Metric | Extracted finding |
|---|---|---|---|---|---|
| outcome-specific | Causal association of epigenetic aging and COVID-19 severity and... | other/mixed | COVID-19 Host Genetics Initiative cohort | - | aging was not a risk factor for the increased severity of COVID-19 (P > 0.05) |
| outcome-specific | Telomere Length and Use of Immunosuppressive Medications in Idiopathic... | other/mixed | patients with idiopathic pulmonary fibrosis and... | - | In PANTHER-IPF, exposure to prednisone/azathioprine/N-acetylcysteine was associated with a higher composite... |

This receipt-backed scoping note has one bounded signal: telomere shows endpoint-specific favorable signals with context limits across this 5-source primary/review bundle (2017-2022). Evidence role grouping: direction-bearing receipts: 3; null/mixed metric-scope caveat receipts: 0; context/antecedent/model receipts: 2 excluded from effect support. The source facts cover 5 population/setting context(s) and 5 intervention/exposure context(s), so this is a scoping signal about where endpoints diverge, without establishing a causal, clinical, species-translated, or mechanistically integrated claim. The listed effect sizes remain source-specific across endpoints and populations; they are not pooled or averaged. This is a heterogeneous indication/context map, not a unified disease-specific or endpoint-family claim. Concrete contrast: other/mixed: Causal association of epigenetic aging and COVID-19 severity and susceptibility: A bidirectional Mendelian randomization study: aging was not a risk factor for the increased severity of COVID-19 (P > 0.05); directionally favorable: Short telomere length is associated with impaired cognitive performance in European ancestry cohorts: longer telomeres were associated with better scores on DSST (β=0.051 per s.d.-increase of TL; 95% CI: 0.024....

## Directional grouping

- directionally favorable: telomere is the intervention/exposure and the reported clinical endpoint favors that arm.
- comparator/not favorable: telomere is the comparator arm; the label is limited to that head-to-head endpoint.
- economic/context only: the receipt reports cost, QALY, or economic context rather than a clinical efficacy endpoint.
- non-clinical/predictive: the receipt reports descriptive modelling, prediction, or age-clock performance rather than an intervention endpoint.
- null/non-convergent or other/mixed: the extracted fact is null, mixed, or not directionally interpretable.

- directionally favorable: Short telomere length is associated with impaired cognitive performance in European ancestry cohorts — longer telomeres were associated with better scores on DSST (β=0.051 per s.d.-increase of TL; 95% CI: 0.024, 0.077; P=0.0002)
- directionally favorable: Genetically Predicted Telomere Length and Its Relationship With Alzheimer’s Disease — longer telomeres were associated with lower risks of AD (odds ratio = 0.79, 95% confidence interval: 0.67, 0.93, P = 0.004)
- other/mixed: Causal association of epigenetic aging and COVID-19 severity and susceptibility: A bidirectional Mendelian randomization study — aging was not a risk factor for the increased severity of COVID-19 (P > 0.05).
- directionally favorable: Telomere Length and All-Cause Mortality: A Meta-analysis — one standard deviation (SD) decrement of leukocyte TL corresponded to 13% increased all-cause mortality risk (95% confidence interval [CI]: 7%-19%)
- other/mixed: Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis — In PANTHER-IPF, exposure to prednisone/azathioprine/N-acetylcysteine was associated with a higher composite endpoint for those with an LTL less than the 10th percentile (hazard ratio, 2.84; 95% confidence interval, 1.02–7.87; P = 0.045).

Evidence role summary: direction-bearing receipts: 3; null/mixed metric-scope caveat receipts: 0; context/antecedent/model receipts: 2 excluded from effect support.
Direction labels for audit: directionally favorable: 3 receipt(s) | other/mixed: 2 receipt(s).

Specific moderators in this bundle are outcome type (odds ratio for Alzheimer's disease risk), population/indication (Alzheimer's disease GWAS summary statistics; COVID-19 Host Genetics Initiative cohort; European ancestry cohorts (N=17,052; mean age=59.2±8.8 years); Swedish Twin Registry cohort, 12,083 individuals with 2517 deaths; patients with idiopathic pulmonary fibrosis and leukocyte telomere length less than the 10th percentile), study design/evidence type (primary/review). Single primary-study estimates are separated from pooled review or meta-analytic estimates rather than treated as interchangeable.

## Context separation

Population/settings are separated as receipt context: Alzheimer's disease GWAS summary statistics, COVID-19 Host Genetics Initiative cohort, European ancestry cohorts (N=17,052; mean age=59.2±8.8 years), Swedish Twin Registry cohort, 12,083 individuals with 2517 deaths, and patients with idiopathic pulmonary fibrosis and leukocyte telomere length less than the 10th percentile. The selected receipts group because each carries a fact-level extraction for telomere; they separate by context (human clinical/observational and other source context) and endpoint, so they are not interchangeable evidence for one pooled claim.

## Boundary limits

Source-literature boundary for telomere: the listed sources define one bounded, context-dependent signal across separate source contexts. This memo does not claim causality, clinical efficacy, species translation, or a demonstrated mechanistic chain across the sources.
 Material limitations: small 5-source bundle; no pooled estimate is possible; method/model receipts without direct effect estimates are context only; endpoints are not harmonized across studies.
 The signal is purely descriptive of source-level direction and scope; it cannot support even a weak causal or comparative-efficacy inference, and pooling across these PICOs would be inappropriate.
 Routing domain `longevity_research` is publication-lane metadata only; the source scope here is defined by the selected telomere receipts.

## What would weaken this

- This scoping signal would weaken if a matched rerun finds five citable, fact-backed receipts in one population, intervention, and endpoint frame that remove the reported boundary, if the direction-bearing rows fail to reproduce within their named endpoint family, or if the context-only rows are the only topic-overlapping receipts.

## Next gaps

A stronger memo needs a new matched PICO that reduces this bundle's heterogeneity: hold outcome=odds ratio for Alzheimer's disease risk constant, compare intervention/exposure=longer genetically predicted leukocyte telomere length (20 SNPs as instrumental variables) against a clearly matched comparator, and test it in a population adjacent to but not duplicating Alzheimer's disease GWAS summary statistics.
If telomere is promoted beyond a scoping note, the next run should select sources sharing one context family rather than spanning human clinical/observational and other source context.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "2ecae67a-eedf-4cb7-90fd-8d960afef0a7",
  "title": "telomere: one bounded, context-dependent signal across receipts"
}